nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiaprofenic acid—PTGS2—urinary bladder cancer	0.563	1	CbGaD
Tiaprofenic acid—PTGS2—Cisplatin—urinary bladder cancer	0.0937	0.356	CbGbCtD
Tiaprofenic acid—PTGS2—Etoposide—urinary bladder cancer	0.0921	0.349	CbGbCtD
Tiaprofenic acid—PTGS1—Etoposide—urinary bladder cancer	0.0778	0.295	CbGbCtD
Tiaprofenic acid—Suprofen—UGT2B7—urinary bladder cancer	0.00202	0.302	CrCbGaD
Tiaprofenic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.00147	0.0505	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—urinary bladder cancer	0.00136	0.0467	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.00117	0.0401	CbGpPWpGaD
Tiaprofenic acid—Flurbiprofen—UGT2B7—urinary bladder cancer	0.00113	0.17	CrCbGaD
Tiaprofenic acid—PTGS1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.001	0.0343	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000795	0.0272	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000702	0.024	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.000638	0.0218	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.00062	0.0212	CbGpPWpGaD
Tiaprofenic acid—Ketoprofen—CXCL8—urinary bladder cancer	0.00058	0.0869	CrCbGaD
Tiaprofenic acid—Ketorolac—PTGS2—urinary bladder cancer	0.000538	0.0806	CrCbGaD
Tiaprofenic acid—PTGS1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000533	0.0183	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—urinary bladder cancer	0.000514	0.0176	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.000482	0.0165	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTZ1—urinary bladder cancer	0.000477	0.0164	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.00047	0.0161	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTO2—urinary bladder cancer	0.000453	0.0155	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Biological oxidations—NAT1—urinary bladder cancer	0.000453	0.0155	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000452	0.0155	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000423	0.0145	CbGpPWpGaD
Tiaprofenic acid—Nepafenac—PTGS2—urinary bladder cancer	0.000417	0.0625	CrCbGaD
Tiaprofenic acid—PTGS1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000414	0.0142	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Overview of nanoparticle effects—PTGS2—urinary bladder cancer	0.000402	0.0138	CbGpPWpGaD
Tiaprofenic acid—Fenbufen—PTGS2—urinary bladder cancer	0.000399	0.0598	CrCbGaD
Tiaprofenic acid—PTGS1—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.00039	0.0134	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000373	0.0128	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000364	0.0125	CbGpPWpGaD
Tiaprofenic acid—PTGS2—S1P1 pathway—RHOA—urinary bladder cancer	0.000353	0.0121	CbGpPWpGaD
Tiaprofenic acid—Salsalate—PTGS2—urinary bladder cancer	0.000347	0.052	CrCbGaD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000335	0.0115	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Eicosanoid Synthesis—PTGS2—urinary bladder cancer	0.000334	0.0114	CbGpPWpGaD
Tiaprofenic acid—Suprofen—PTGS2—urinary bladder cancer	0.000333	0.0498	CrCbGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.000322	0.011	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000315	0.0108	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.00031	0.0106	CbGpPWpGaD
Tiaprofenic acid—Fenoprofen—PTGS2—urinary bladder cancer	0.000287	0.0429	CrCbGaD
Tiaprofenic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—urinary bladder cancer	0.000279	0.00957	CbGpPWpGaD
Tiaprofenic acid—Anaemia—Etoposide—urinary bladder cancer	0.000279	0.00205	CcSEcCtD
Tiaprofenic acid—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000279	0.00204	CcSEcCtD
Tiaprofenic acid—Hot flush—Doxorubicin—urinary bladder cancer	0.000278	0.00204	CcSEcCtD
Tiaprofenic acid—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000277	0.00204	CcSEcCtD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000276	0.00945	CbGpPWpGaD
Tiaprofenic acid—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.000275	0.00202	CcSEcCtD
Tiaprofenic acid—Anorexia—Gemcitabine—urinary bladder cancer	0.000275	0.00202	CcSEcCtD
Tiaprofenic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—urinary bladder cancer	0.000273	0.00935	CbGpPWpGaD
Tiaprofenic acid—Urticaria—Thiotepa—urinary bladder cancer	0.000272	0.002	CcSEcCtD
Tiaprofenic acid—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.000272	0.00199	CcSEcCtD
Tiaprofenic acid—PTGS1—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000272	0.00931	CbGpPWpGaD
Tiaprofenic acid—Vertigo—Etoposide—urinary bladder cancer	0.000271	0.00199	CcSEcCtD
Tiaprofenic acid—Abdominal pain—Thiotepa—urinary bladder cancer	0.000271	0.00199	CcSEcCtD
Tiaprofenic acid—Anorexia—Fluorouracil—urinary bladder cancer	0.00027	0.00198	CcSEcCtD
Tiaprofenic acid—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00027	0.00198	CcSEcCtD
Tiaprofenic acid—Purpura—Doxorubicin—urinary bladder cancer	0.000269	0.00198	CcSEcCtD
Tiaprofenic acid—Oedema—Cisplatin—urinary bladder cancer	0.000269	0.00197	CcSEcCtD
Tiaprofenic acid—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000269	0.00197	CcSEcCtD
Tiaprofenic acid—Mefenamic acid—PTGS2—urinary bladder cancer	0.000266	0.0398	CrCbGaD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000266	0.0091	CbGpPWpGaD
Tiaprofenic acid—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000263	0.00193	CcSEcCtD
Tiaprofenic acid—Insomnia—Gemcitabine—urinary bladder cancer	0.000261	0.00191	CcSEcCtD
Tiaprofenic acid—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.00026	0.00191	CcSEcCtD
Tiaprofenic acid—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00026	0.00191	CcSEcCtD
Tiaprofenic acid—Asthma—Methotrexate—urinary bladder cancer	0.000259	0.0019	CcSEcCtD
Tiaprofenic acid—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000259	0.0019	CcSEcCtD
Tiaprofenic acid—Dry skin—Epirubicin—urinary bladder cancer	0.000257	0.00189	CcSEcCtD
Tiaprofenic acid—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000257	0.00189	CcSEcCtD
Tiaprofenic acid—Chest pain—Etoposide—urinary bladder cancer	0.000257	0.00188	CcSEcCtD
Tiaprofenic acid—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000256	0.00188	CcSEcCtD
Tiaprofenic acid—Insomnia—Fluorouracil—urinary bladder cancer	0.000256	0.00188	CcSEcCtD
Tiaprofenic acid—Somnolence—Gemcitabine—urinary bladder cancer	0.000256	0.00188	CcSEcCtD
Tiaprofenic acid—Anorexia—Cisplatin—urinary bladder cancer	0.000256	0.00188	CcSEcCtD
Tiaprofenic acid—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000254	0.00187	CcSEcCtD
Tiaprofenic acid—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000253	0.00185	CcSEcCtD
Tiaprofenic acid—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000253	0.00185	CcSEcCtD
Tiaprofenic acid—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000252	0.00185	CcSEcCtD
Tiaprofenic acid—Somnolence—Fluorouracil—urinary bladder cancer	0.000252	0.00185	CcSEcCtD
Tiaprofenic acid—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000251	0.00184	CcSEcCtD
Tiaprofenic acid—PTGS2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00025	0.00857	CbGpPWpGaD
Tiaprofenic acid—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000249	0.00183	CcSEcCtD
Tiaprofenic acid—Fatigue—Gemcitabine—urinary bladder cancer	0.000248	0.00182	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—NAT2—urinary bladder cancer	0.000248	0.0085	CbGpPWpGaD
Tiaprofenic acid—Constipation—Gemcitabine—urinary bladder cancer	0.000246	0.00181	CcSEcCtD
Tiaprofenic acid—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000246	0.00181	CcSEcCtD
Tiaprofenic acid—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000246	0.00181	CcSEcCtD
Tiaprofenic acid—Asthenia—Thiotepa—urinary bladder cancer	0.000246	0.0018	CcSEcCtD
Tiaprofenic acid—Asthma—Epirubicin—urinary bladder cancer	0.000243	0.00178	CcSEcCtD
Tiaprofenic acid—Dysuria—Methotrexate—urinary bladder cancer	0.000242	0.00178	CcSEcCtD
Tiaprofenic acid—Pruritus—Thiotepa—urinary bladder cancer	0.000242	0.00178	CcSEcCtD
Tiaprofenic acid—Paraesthesia—Cisplatin—urinary bladder cancer	0.000241	0.00177	CcSEcCtD
Tiaprofenic acid—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000241	0.00177	CcSEcCtD
Tiaprofenic acid—Dyspnoea—Cisplatin—urinary bladder cancer	0.000239	0.00176	CcSEcCtD
Tiaprofenic acid—Dry skin—Doxorubicin—urinary bladder cancer	0.000238	0.00175	CcSEcCtD
Tiaprofenic acid—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000238	0.00175	CcSEcCtD
Tiaprofenic acid—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000237	0.00174	CcSEcCtD
Tiaprofenic acid—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000237	0.00174	CcSEcCtD
Tiaprofenic acid—Angina pectoris—Epirubicin—urinary bladder cancer	0.000236	0.00173	CcSEcCtD
Tiaprofenic acid—Anorexia—Etoposide—urinary bladder cancer	0.000235	0.00172	CcSEcCtD
Tiaprofenic acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.000234	0.00172	CcSEcCtD
Tiaprofenic acid—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000234	0.00172	CcSEcCtD
Tiaprofenic acid—Decreased appetite—Cisplatin—urinary bladder cancer	0.000234	0.00171	CcSEcCtD
Tiaprofenic acid—Drowsiness—Methotrexate—urinary bladder cancer	0.000231	0.0017	CcSEcCtD
Tiaprofenic acid—Depression—Methotrexate—urinary bladder cancer	0.00023	0.00169	CcSEcCtD
Tiaprofenic acid—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000229	0.00168	CcSEcCtD
Tiaprofenic acid—Dysuria—Epirubicin—urinary bladder cancer	0.000227	0.00166	CcSEcCtD
Tiaprofenic acid—Dizziness—Thiotepa—urinary bladder cancer	0.000227	0.00166	CcSEcCtD
Tiaprofenic acid—Stomatitis—Methotrexate—urinary bladder cancer	0.000225	0.00165	CcSEcCtD
Tiaprofenic acid—Urticaria—Fluorouracil—urinary bladder cancer	0.000225	0.00165	CcSEcCtD
Tiaprofenic acid—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000225	0.00165	CcSEcCtD
Tiaprofenic acid—Asthma—Doxorubicin—urinary bladder cancer	0.000224	0.00165	CcSEcCtD
Tiaprofenic acid—Pollakiuria—Epirubicin—urinary bladder cancer	0.000224	0.00164	CcSEcCtD
Tiaprofenic acid—Sweating—Methotrexate—urinary bladder cancer	0.000222	0.00163	CcSEcCtD
Tiaprofenic acid—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000221	0.00162	CcSEcCtD
Tiaprofenic acid—Paraesthesia—Etoposide—urinary bladder cancer	0.000221	0.00162	CcSEcCtD
Tiaprofenic acid—Weight increased—Epirubicin—urinary bladder cancer	0.000221	0.00162	CcSEcCtD
Tiaprofenic acid—Haematuria—Methotrexate—urinary bladder cancer	0.00022	0.00162	CcSEcCtD
Tiaprofenic acid—Dyspnoea—Etoposide—urinary bladder cancer	0.000219	0.00161	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000219	0.00752	CbGpPWpGaD
Tiaprofenic acid—Somnolence—Etoposide—urinary bladder cancer	0.000219	0.00161	CcSEcCtD
Tiaprofenic acid—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000219	0.0016	CcSEcCtD
Tiaprofenic acid—Epistaxis—Methotrexate—urinary bladder cancer	0.000218	0.0016	CcSEcCtD
Tiaprofenic acid—Vomiting—Thiotepa—urinary bladder cancer	0.000218	0.0016	CcSEcCtD
Tiaprofenic acid—Drowsiness—Epirubicin—urinary bladder cancer	0.000216	0.00159	CcSEcCtD
Tiaprofenic acid—Rash—Thiotepa—urinary bladder cancer	0.000216	0.00159	CcSEcCtD
Tiaprofenic acid—Dermatitis—Thiotepa—urinary bladder cancer	0.000216	0.00158	CcSEcCtD
Tiaprofenic acid—PTGS2—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000216	0.00739	CbGpPWpGaD
Tiaprofenic acid—Headache—Thiotepa—urinary bladder cancer	0.000215	0.00157	CcSEcCtD
Tiaprofenic acid—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000214	0.00157	CcSEcCtD
Tiaprofenic acid—Decreased appetite—Etoposide—urinary bladder cancer	0.000214	0.00157	CcSEcCtD
Tiaprofenic acid—Fatigue—Etoposide—urinary bladder cancer	0.000212	0.00156	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—urinary bladder cancer	0.000211	0.00723	CbGpPWpGaD
Tiaprofenic acid—Stomatitis—Epirubicin—urinary bladder cancer	0.000211	0.00155	CcSEcCtD
Tiaprofenic acid—Constipation—Etoposide—urinary bladder cancer	0.00021	0.00154	CcSEcCtD
Tiaprofenic acid—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00021	0.00154	CcSEcCtD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.00021	0.0072	CbGpPWpGaD
Tiaprofenic acid—Dysuria—Doxorubicin—urinary bladder cancer	0.00021	0.00154	CcSEcCtD
Tiaprofenic acid—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000209	0.00153	CcSEcCtD
Tiaprofenic acid—Haemoglobin—Methotrexate—urinary bladder cancer	0.000209	0.00153	CcSEcCtD
Tiaprofenic acid—Haemorrhage—Methotrexate—urinary bladder cancer	0.000207	0.00152	CcSEcCtD
Tiaprofenic acid—Sweating—Epirubicin—urinary bladder cancer	0.000207	0.00152	CcSEcCtD
Tiaprofenic acid—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000207	0.00152	CcSEcCtD
Tiaprofenic acid—Asthenia—Gemcitabine—urinary bladder cancer	0.000207	0.00152	CcSEcCtD
Tiaprofenic acid—Haematuria—Epirubicin—urinary bladder cancer	0.000206	0.00151	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000206	0.00706	CbGpPWpGaD
Tiaprofenic acid—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000205	0.0015	CcSEcCtD
Tiaprofenic acid—Weight increased—Doxorubicin—urinary bladder cancer	0.000204	0.0015	CcSEcCtD
Tiaprofenic acid—Epistaxis—Epirubicin—urinary bladder cancer	0.000204	0.0015	CcSEcCtD
Tiaprofenic acid—Pruritus—Gemcitabine—urinary bladder cancer	0.000204	0.0015	CcSEcCtD
Tiaprofenic acid—Nausea—Thiotepa—urinary bladder cancer	0.000203	0.00149	CcSEcCtD
Tiaprofenic acid—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000201	0.00148	CcSEcCtD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000201	0.00687	CbGpPWpGaD
Tiaprofenic acid—Pruritus—Fluorouracil—urinary bladder cancer	0.0002	0.00147	CcSEcCtD
Tiaprofenic acid—Drowsiness—Doxorubicin—urinary bladder cancer	0.0002	0.00147	CcSEcCtD
Tiaprofenic acid—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000198	0.00146	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—HPGDS—urinary bladder cancer	0.000198	0.00679	CbGpPWpGaD
Tiaprofenic acid—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000198	0.00145	CcSEcCtD
Tiaprofenic acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000197	0.00145	CcSEcCtD
Tiaprofenic acid—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000196	0.00144	CcSEcCtD
Tiaprofenic acid—Urticaria—Etoposide—urinary bladder cancer	0.000195	0.00143	CcSEcCtD
Tiaprofenic acid—Haemoglobin—Epirubicin—urinary bladder cancer	0.000195	0.00143	CcSEcCtD
Tiaprofenic acid—Stomatitis—Doxorubicin—urinary bladder cancer	0.000195	0.00143	CcSEcCtD
Tiaprofenic acid—Abdominal pain—Etoposide—urinary bladder cancer	0.000195	0.00143	CcSEcCtD
Tiaprofenic acid—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000195	0.00143	CcSEcCtD
Tiaprofenic acid—Haemorrhage—Epirubicin—urinary bladder cancer	0.000194	0.00142	CcSEcCtD
Tiaprofenic acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000194	0.00142	CcSEcCtD
Tiaprofenic acid—Tinnitus—Methotrexate—urinary bladder cancer	0.000193	0.00142	CcSEcCtD
Tiaprofenic acid—Asthenia—Cisplatin—urinary bladder cancer	0.000193	0.00141	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTT1—urinary bladder cancer	0.000192	0.00659	CbGpPWpGaD
Tiaprofenic acid—Sweating—Doxorubicin—urinary bladder cancer	0.000192	0.00141	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000192	0.00656	CbGpPWpGaD
Tiaprofenic acid—Haematuria—Doxorubicin—urinary bladder cancer	0.000191	0.0014	CcSEcCtD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.00019	0.0065	CbGpPWpGaD
Tiaprofenic acid—Epistaxis—Doxorubicin—urinary bladder cancer	0.000189	0.00139	CcSEcCtD
Tiaprofenic acid—Dizziness—Fluorouracil—urinary bladder cancer	0.000187	0.00137	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000187	0.00641	CbGpPWpGaD
Tiaprofenic acid—Flurbiprofen—PTGS2—urinary bladder cancer	0.000187	0.028	CrCbGaD
Tiaprofenic acid—PTGS1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000186	0.00636	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000185	0.00634	CbGpPWpGaD
Tiaprofenic acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.000184	0.00135	CcSEcCtD
Tiaprofenic acid—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000184	0.00135	CcSEcCtD
Tiaprofenic acid—Vomiting—Gemcitabine—urinary bladder cancer	0.000183	0.00134	CcSEcCtD
Tiaprofenic acid—Rash—Gemcitabine—urinary bladder cancer	0.000182	0.00133	CcSEcCtD
Tiaprofenic acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.000182	0.00133	CcSEcCtD
Tiaprofenic acid—Hypersensitivity—Etoposide—urinary bladder cancer	0.000181	0.00133	CcSEcCtD
Tiaprofenic acid—Tinnitus—Epirubicin—urinary bladder cancer	0.000181	0.00133	CcSEcCtD
Tiaprofenic acid—Erythema—Methotrexate—urinary bladder cancer	0.000181	0.00133	CcSEcCtD
Tiaprofenic acid—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000181	0.00133	CcSEcCtD
Tiaprofenic acid—Headache—Gemcitabine—urinary bladder cancer	0.000181	0.00132	CcSEcCtD
Tiaprofenic acid—Vomiting—Fluorouracil—urinary bladder cancer	0.00018	0.00132	CcSEcCtD
Tiaprofenic acid—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00018	0.00132	CcSEcCtD
Tiaprofenic acid—Rash—Fluorouracil—urinary bladder cancer	0.000179	0.00131	CcSEcCtD
Tiaprofenic acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.000178	0.00131	CcSEcCtD
Tiaprofenic acid—Headache—Fluorouracil—urinary bladder cancer	0.000178	0.0013	CcSEcCtD
Tiaprofenic acid—Asthenia—Etoposide—urinary bladder cancer	0.000177	0.0013	CcSEcCtD
Tiaprofenic acid—Pruritus—Etoposide—urinary bladder cancer	0.000174	0.00128	CcSEcCtD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000173	0.00591	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000173	0.00591	CbGpPWpGaD
Tiaprofenic acid—Nausea—Gemcitabine—urinary bladder cancer	0.000171	0.00126	CcSEcCtD
Tiaprofenic acid—Vomiting—Cisplatin—urinary bladder cancer	0.000171	0.00125	CcSEcCtD
Tiaprofenic acid—Vision blurred—Methotrexate—urinary bladder cancer	0.00017	0.00125	CcSEcCtD
Tiaprofenic acid—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00017	0.00125	CcSEcCtD
Tiaprofenic acid—Rash—Cisplatin—urinary bladder cancer	0.000169	0.00124	CcSEcCtD
Tiaprofenic acid—Dermatitis—Cisplatin—urinary bladder cancer	0.000169	0.00124	CcSEcCtD
Tiaprofenic acid—Ketoprofen—PTGS2—urinary bladder cancer	0.000169	0.0253	CrCbGaD
Tiaprofenic acid—Erythema—Epirubicin—urinary bladder cancer	0.000169	0.00124	CcSEcCtD
Tiaprofenic acid—Diarrhoea—Etoposide—urinary bladder cancer	0.000168	0.00124	CcSEcCtD
Tiaprofenic acid—Nausea—Fluorouracil—urinary bladder cancer	0.000168	0.00124	CcSEcCtD
Tiaprofenic acid—Tinnitus—Doxorubicin—urinary bladder cancer	0.000168	0.00123	CcSEcCtD
Tiaprofenic acid—Anaemia—Methotrexate—urinary bladder cancer	0.000167	0.00122	CcSEcCtD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000167	0.00572	CbGpPWpGaD
Tiaprofenic acid—Flatulence—Epirubicin—urinary bladder cancer	0.000167	0.00122	CcSEcCtD
Tiaprofenic acid—Dizziness—Etoposide—urinary bladder cancer	0.000163	0.00119	CcSEcCtD
Tiaprofenic acid—Muscle spasms—Epirubicin—urinary bladder cancer	0.000163	0.00119	CcSEcCtD
Tiaprofenic acid—Vertigo—Methotrexate—urinary bladder cancer	0.000162	0.00119	CcSEcCtD
Tiaprofenic acid—Nausea—Cisplatin—urinary bladder cancer	0.00016	0.00117	CcSEcCtD
Tiaprofenic acid—Vision blurred—Epirubicin—urinary bladder cancer	0.000159	0.00117	CcSEcCtD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000159	0.00545	CbGpPWpGaD
Tiaprofenic acid—Vomiting—Etoposide—urinary bladder cancer	0.000156	0.00115	CcSEcCtD
Tiaprofenic acid—Erythema—Doxorubicin—urinary bladder cancer	0.000156	0.00115	CcSEcCtD
Tiaprofenic acid—Anaemia—Epirubicin—urinary bladder cancer	0.000156	0.00115	CcSEcCtD
Tiaprofenic acid—Rash—Etoposide—urinary bladder cancer	0.000155	0.00114	CcSEcCtD
Tiaprofenic acid—Dermatitis—Etoposide—urinary bladder cancer	0.000155	0.00114	CcSEcCtD
Tiaprofenic acid—Headache—Etoposide—urinary bladder cancer	0.000154	0.00113	CcSEcCtD
Tiaprofenic acid—Flatulence—Doxorubicin—urinary bladder cancer	0.000154	0.00113	CcSEcCtD
Tiaprofenic acid—Chest pain—Methotrexate—urinary bladder cancer	0.000154	0.00113	CcSEcCtD
Tiaprofenic acid—Vertigo—Epirubicin—urinary bladder cancer	0.000152	0.00111	CcSEcCtD
Tiaprofenic acid—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00015	0.0011	CcSEcCtD
Tiaprofenic acid—Palpitations—Epirubicin—urinary bladder cancer	0.000149	0.0011	CcSEcCtD
Tiaprofenic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000148	0.00508	CbGpPWpGaD
Tiaprofenic acid—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000147	0.00108	CcSEcCtD
Tiaprofenic acid—Vision blurred—Doxorubicin—urinary bladder cancer	0.000147	0.00108	CcSEcCtD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000147	0.00503	CbGpPWpGaD
Tiaprofenic acid—Nausea—Etoposide—urinary bladder cancer	0.000146	0.00107	CcSEcCtD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000145	0.00496	CbGpPWpGaD
Tiaprofenic acid—Anaemia—Doxorubicin—urinary bladder cancer	0.000145	0.00106	CcSEcCtD
Tiaprofenic acid—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000144	0.00106	CcSEcCtD
Tiaprofenic acid—Chest pain—Epirubicin—urinary bladder cancer	0.000144	0.00106	CcSEcCtD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000144	0.00493	CbGpPWpGaD
Tiaprofenic acid—Anxiety—Epirubicin—urinary bladder cancer	0.000143	0.00105	CcSEcCtD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000143	0.0049	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.000143	0.00489	CbGpPWpGaD
Tiaprofenic acid—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000142	0.00105	CcSEcCtD
Tiaprofenic acid—Dry mouth—Epirubicin—urinary bladder cancer	0.000141	0.00103	CcSEcCtD
Tiaprofenic acid—Vertigo—Doxorubicin—urinary bladder cancer	0.000141	0.00103	CcSEcCtD
Tiaprofenic acid—Anorexia—Methotrexate—urinary bladder cancer	0.000141	0.00103	CcSEcCtD
Tiaprofenic acid—Palpitations—Doxorubicin—urinary bladder cancer	0.000138	0.00101	CcSEcCtD
Tiaprofenic acid—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000138	0.00101	CcSEcCtD
Tiaprofenic acid—Oedema—Epirubicin—urinary bladder cancer	0.000138	0.00101	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000138	0.00472	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000137	0.00468	CbGpPWpGaD
Tiaprofenic acid—PTGS1—prostate gland—urinary bladder cancer	0.000136	0.0904	CbGeAlD
Tiaprofenic acid—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000135	0.000991	CcSEcCtD
Tiaprofenic acid—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000133	0.000979	CcSEcCtD
Tiaprofenic acid—Insomnia—Methotrexate—urinary bladder cancer	0.000133	0.000978	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000133	0.00457	CbGpPWpGaD
Tiaprofenic acid—Chest pain—Doxorubicin—urinary bladder cancer	0.000133	0.000977	CcSEcCtD
Tiaprofenic acid—Anxiety—Doxorubicin—urinary bladder cancer	0.000133	0.000974	CcSEcCtD
Tiaprofenic acid—Paraesthesia—Methotrexate—urinary bladder cancer	0.000132	0.000971	CcSEcCtD
Tiaprofenic acid—Anorexia—Epirubicin—urinary bladder cancer	0.000131	0.000965	CcSEcCtD
Tiaprofenic acid—Dyspnoea—Methotrexate—urinary bladder cancer	0.000131	0.000964	CcSEcCtD
Tiaprofenic acid—Somnolence—Methotrexate—urinary bladder cancer	0.000131	0.000962	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000131	0.00449	CbGpPWpGaD
Tiaprofenic acid—Dry mouth—Doxorubicin—urinary bladder cancer	0.00013	0.000956	CcSEcCtD
Tiaprofenic acid—PTGS2—prostate gland—urinary bladder cancer	0.00013	0.0864	CbGeAlD
Tiaprofenic acid—Dyspepsia—Methotrexate—urinary bladder cancer	0.00013	0.000952	CcSEcCtD
Tiaprofenic acid—Decreased appetite—Methotrexate—urinary bladder cancer	0.000128	0.00094	CcSEcCtD
Tiaprofenic acid—Oedema—Doxorubicin—urinary bladder cancer	0.000128	0.000937	CcSEcCtD
Tiaprofenic acid—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000128	0.000937	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000127	0.00436	CbGpPWpGaD
Tiaprofenic acid—Fatigue—Methotrexate—urinary bladder cancer	0.000127	0.000933	CcSEcCtD
Tiaprofenic acid—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000125	0.000917	CcSEcCtD
Tiaprofenic acid—Insomnia—Epirubicin—urinary bladder cancer	0.000125	0.000916	CcSEcCtD
Tiaprofenic acid—Paraesthesia—Epirubicin—urinary bladder cancer	0.000124	0.000909	CcSEcCtD
Tiaprofenic acid—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000123	0.000905	CcSEcCtD
Tiaprofenic acid—Dyspnoea—Epirubicin—urinary bladder cancer	0.000123	0.000902	CcSEcCtD
Tiaprofenic acid—Somnolence—Epirubicin—urinary bladder cancer	0.000123	0.0009	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000122	0.0042	CbGpPWpGaD
Tiaprofenic acid—Anorexia—Doxorubicin—urinary bladder cancer	0.000122	0.000893	CcSEcCtD
Tiaprofenic acid—Dyspepsia—Epirubicin—urinary bladder cancer	0.000121	0.000891	CcSEcCtD
Tiaprofenic acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000121	0.000884	CcSEcCtD
Tiaprofenic acid—Decreased appetite—Epirubicin—urinary bladder cancer	0.00012	0.00088	CcSEcCtD
Tiaprofenic acid—Fatigue—Epirubicin—urinary bladder cancer	0.000119	0.000873	CcSEcCtD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000119	0.00407	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000118	0.00404	CbGpPWpGaD
Tiaprofenic acid—Constipation—Epirubicin—urinary bladder cancer	0.000118	0.000866	CcSEcCtD
Tiaprofenic acid—Urticaria—Methotrexate—urinary bladder cancer	0.000117	0.000859	CcSEcCtD
Tiaprofenic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000117	0.004	CbGpPWpGaD
Tiaprofenic acid—Abdominal pain—Methotrexate—urinary bladder cancer	0.000117	0.000855	CcSEcCtD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000116	0.00397	CbGpPWpGaD
Tiaprofenic acid—Insomnia—Doxorubicin—urinary bladder cancer	0.000115	0.000847	CcSEcCtD
Tiaprofenic acid—PTGS1—seminal vesicle—urinary bladder cancer	0.000115	0.0765	CbGeAlD
Tiaprofenic acid—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000115	0.000841	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000114	0.00391	CbGpPWpGaD
Tiaprofenic acid—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000114	0.000835	CcSEcCtD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000114	0.00389	CbGpPWpGaD
Tiaprofenic acid—Somnolence—Doxorubicin—urinary bladder cancer	0.000113	0.000833	CcSEcCtD
Tiaprofenic acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000113	0.000828	CcSEcCtD
Tiaprofenic acid—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000112	0.000824	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000112	0.00382	CbGpPWpGaD
Tiaprofenic acid—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000111	0.000814	CcSEcCtD
Tiaprofenic acid—Fatigue—Doxorubicin—urinary bladder cancer	0.00011	0.000807	CcSEcCtD
Tiaprofenic acid—PTGS2—seminal vesicle—urinary bladder cancer	0.00011	0.0731	CbGeAlD
Tiaprofenic acid—Urticaria—Epirubicin—urinary bladder cancer	0.00011	0.000804	CcSEcCtD
Tiaprofenic acid—Constipation—Doxorubicin—urinary bladder cancer	0.000109	0.000801	CcSEcCtD
Tiaprofenic acid—Abdominal pain—Epirubicin—urinary bladder cancer	0.000109	0.0008	CcSEcCtD
Tiaprofenic acid—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000109	0.000797	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000106	0.00364	CbGpPWpGaD
Tiaprofenic acid—Asthenia—Methotrexate—urinary bladder cancer	0.000106	0.000776	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000105	0.00361	CbGpPWpGaD
Tiaprofenic acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000104	0.000766	CcSEcCtD
Tiaprofenic acid—Pruritus—Methotrexate—urinary bladder cancer	0.000104	0.000765	CcSEcCtD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.000104	0.00356	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	0.000104	0.00355	CbGpPWpGaD
Tiaprofenic acid—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000102	0.000746	CcSEcCtD
Tiaprofenic acid—Urticaria—Doxorubicin—urinary bladder cancer	0.000101	0.000744	CcSEcCtD
Tiaprofenic acid—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000101	0.00074	CcSEcCtD
Tiaprofenic acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.000101	0.00074	CcSEcCtD
Tiaprofenic acid—PTGS1—epithelium—urinary bladder cancer	9.98e-05	0.0664	CbGeAlD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	9.94e-05	0.00341	CbGpPWpGaD
Tiaprofenic acid—Asthenia—Epirubicin—urinary bladder cancer	9.9e-05	0.000726	CcSEcCtD
Tiaprofenic acid—Pruritus—Epirubicin—urinary bladder cancer	9.76e-05	0.000716	CcSEcCtD
Tiaprofenic acid—Dizziness—Methotrexate—urinary bladder cancer	9.75e-05	0.000715	CcSEcCtD
Tiaprofenic acid—PTGS1—smooth muscle tissue—urinary bladder cancer	9.62e-05	0.064	CbGeAlD
Tiaprofenic acid—PTGS2—epithelium—urinary bladder cancer	9.54e-05	0.0635	CbGeAlD
Tiaprofenic acid—Diarrhoea—Epirubicin—urinary bladder cancer	9.44e-05	0.000693	CcSEcCtD
Tiaprofenic acid—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.4e-05	0.00069	CcSEcCtD
Tiaprofenic acid—Vomiting—Methotrexate—urinary bladder cancer	9.37e-05	0.000688	CcSEcCtD
Tiaprofenic acid—Rash—Methotrexate—urinary bladder cancer	9.29e-05	0.000682	CcSEcCtD
Tiaprofenic acid—Dermatitis—Methotrexate—urinary bladder cancer	9.29e-05	0.000681	CcSEcCtD
Tiaprofenic acid—PTGS1—renal system—urinary bladder cancer	9.26e-05	0.0616	CbGeAlD
Tiaprofenic acid—Headache—Methotrexate—urinary bladder cancer	9.23e-05	0.000678	CcSEcCtD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	9.21e-05	0.00316	CbGpPWpGaD
Tiaprofenic acid—PTGS2—smooth muscle tissue—urinary bladder cancer	9.19e-05	0.0612	CbGeAlD
Tiaprofenic acid—Asthenia—Doxorubicin—urinary bladder cancer	9.16e-05	0.000672	CcSEcCtD
Tiaprofenic acid—Dizziness—Epirubicin—urinary bladder cancer	9.12e-05	0.000669	CcSEcCtD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	9.05e-05	0.0031	CbGpPWpGaD
Tiaprofenic acid—Pruritus—Doxorubicin—urinary bladder cancer	9.03e-05	0.000663	CcSEcCtD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	9.02e-05	0.00309	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	8.96e-05	0.00307	CbGpPWpGaD
Tiaprofenic acid—PTGS2—renal system—urinary bladder cancer	8.85e-05	0.0589	CbGeAlD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	8.79e-05	0.00301	CbGpPWpGaD
Tiaprofenic acid—Vomiting—Epirubicin—urinary bladder cancer	8.77e-05	0.000644	CcSEcCtD
Tiaprofenic acid—Nausea—Methotrexate—urinary bladder cancer	8.76e-05	0.000642	CcSEcCtD
Tiaprofenic acid—Diarrhoea—Doxorubicin—urinary bladder cancer	8.73e-05	0.000641	CcSEcCtD
Tiaprofenic acid—Rash—Epirubicin—urinary bladder cancer	8.7e-05	0.000638	CcSEcCtD
Tiaprofenic acid—PTGS2—urethra—urinary bladder cancer	8.69e-05	0.0578	CbGeAlD
Tiaprofenic acid—Dermatitis—Epirubicin—urinary bladder cancer	8.69e-05	0.000638	CcSEcCtD
Tiaprofenic acid—Headache—Epirubicin—urinary bladder cancer	8.64e-05	0.000634	CcSEcCtD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	8.5e-05	0.00291	CbGpPWpGaD
Tiaprofenic acid—Dizziness—Doxorubicin—urinary bladder cancer	8.44e-05	0.000619	CcSEcCtD
Tiaprofenic acid—Nausea—Epirubicin—urinary bladder cancer	8.19e-05	0.000601	CcSEcCtD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	8.19e-05	0.0028	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	8.17e-05	0.0028	CbGpPWpGaD
Tiaprofenic acid—Vomiting—Doxorubicin—urinary bladder cancer	8.12e-05	0.000596	CcSEcCtD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	8.09e-05	0.00277	CbGpPWpGaD
Tiaprofenic acid—Rash—Doxorubicin—urinary bladder cancer	8.05e-05	0.000591	CcSEcCtD
Tiaprofenic acid—Dermatitis—Doxorubicin—urinary bladder cancer	8.04e-05	0.00059	CcSEcCtD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	8.02e-05	0.00275	CbGpPWpGaD
Tiaprofenic acid—Headache—Doxorubicin—urinary bladder cancer	8e-05	0.000587	CcSEcCtD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.97e-05	0.00273	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTO2—urinary bladder cancer	7.74e-05	0.00265	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—NAT1—urinary bladder cancer	7.74e-05	0.00265	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.61e-05	0.00261	CbGpPWpGaD
Tiaprofenic acid—Nausea—Doxorubicin—urinary bladder cancer	7.58e-05	0.000556	CcSEcCtD
Tiaprofenic acid—PTGS1—female reproductive system—urinary bladder cancer	7.41e-05	0.0493	CbGeAlD
Tiaprofenic acid—PTGS2—Disease—GSTO2—urinary bladder cancer	7.34e-05	0.00251	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	7.19e-05	0.00246	CbGpPWpGaD
Tiaprofenic acid—PTGS2—female reproductive system—urinary bladder cancer	7.09e-05	0.0472	CbGeAlD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	7.08e-05	0.00243	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	7.08e-05	0.00243	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.05e-05	0.00242	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	7.05e-05	0.00241	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	7.02e-05	0.00241	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	6.87e-05	0.00235	CbGpPWpGaD
Tiaprofenic acid—PTGS1—vagina—urinary bladder cancer	6.71e-05	0.0446	CbGeAlD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	6.7e-05	0.00229	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	6.51e-05	0.00223	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	6.5e-05	0.00223	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	6.48e-05	0.00222	CbGpPWpGaD
Tiaprofenic acid—PTGS2—vagina—urinary bladder cancer	6.41e-05	0.0427	CbGeAlD
Tiaprofenic acid—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	6.37e-05	0.00218	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	6.33e-05	0.00217	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.16e-05	0.00211	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTO2—urinary bladder cancer	6.14e-05	0.00211	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—NAT1—urinary bladder cancer	6.14e-05	0.00211	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.08e-05	0.00208	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.04e-05	0.00207	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	6.02e-05	0.00206	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PRSS3—urinary bladder cancer	5.87e-05	0.00201	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—SLC19A1—urinary bladder cancer	5.71e-05	0.00195	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	5.62e-05	0.00193	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—PRSS3—urinary bladder cancer	5.56e-05	0.00191	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	5.54e-05	0.0019	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	5.37e-05	0.00184	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—HDAC4—urinary bladder cancer	5.3e-05	0.00182	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	5.25e-05	0.0018	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.16e-05	0.00177	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	5.06e-05	0.00173	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	5e-05	0.00171	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	4.78e-05	0.00164	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.7e-05	0.00161	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—TYMP—urinary bladder cancer	4.69e-05	0.00161	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PRSS3—urinary bladder cancer	4.66e-05	0.0016	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.55e-05	0.00156	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.5e-05	0.00154	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	4.41e-05	0.00151	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.41e-05	0.00151	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.4e-05	0.00151	CbGpPWpGaD
Tiaprofenic acid—PTGS1—lymph node—urinary bladder cancer	4.34e-05	0.0289	CbGeAlD
Tiaprofenic acid—PTGS1—Metabolism—NAT2—urinary bladder cancer	4.24e-05	0.00145	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—LIG1—urinary bladder cancer	4.21e-05	0.00144	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.19e-05	0.00144	CbGpPWpGaD
Tiaprofenic acid—PTGS2—lymph node—urinary bladder cancer	4.15e-05	0.0276	CbGeAlD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.08e-05	0.0014	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.73e-05	0.00128	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—TYMP—urinary bladder cancer	3.72e-05	0.00128	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—RRM2—urinary bladder cancer	3.66e-05	0.00125	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.65e-05	0.00125	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.58e-05	0.00123	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.57e-05	0.00122	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.4e-05	0.00117	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.39e-05	0.00116	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.39e-05	0.00116	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.38e-05	0.00116	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.37e-05	0.00115	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—NAT2—urinary bladder cancer	3.37e-05	0.00115	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.29e-05	0.00113	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.24e-05	0.00111	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—ENO2—urinary bladder cancer	3.21e-05	0.0011	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—RBX1—urinary bladder cancer	3.05e-05	0.00104	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3e-05	0.00103	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.91e-05	0.000996	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.73e-05	0.000936	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—JAG1—urinary bladder cancer	2.73e-05	0.000934	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.69e-05	0.000922	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.69e-05	0.000922	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.68e-05	0.000917	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.65e-05	0.000908	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.61e-05	0.000894	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.57e-05	0.000881	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.31e-05	0.000792	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.28e-05	0.000781	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.21e-05	0.000756	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—NQO1—urinary bladder cancer	2.17e-05	0.000743	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.12e-05	0.000726	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.09e-05	0.000718	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.09e-05	0.000718	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.01e-05	0.000687	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—NCOR1—urinary bladder cancer	1.99e-05	0.00068	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.97e-05	0.000675	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—ERCC2—urinary bladder cancer	1.87e-05	0.00064	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.85e-05	0.000634	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.84e-05	0.000629	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.81e-05	0.00062	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—MTHFR—urinary bladder cancer	1.75e-05	0.000601	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.75e-05	0.0006	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—TERT—urinary bladder cancer	1.75e-05	0.0006	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.68e-05	0.000576	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.66e-05	0.00057	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.66e-05	0.00057	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—FGFR3—urinary bladder cancer	1.61e-05	0.00055	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.59e-05	0.000546	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.56e-05	0.000536	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.5e-05	0.000514	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.47e-05	0.000504	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.44e-05	0.000494	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—CREBBP—urinary bladder cancer	1.37e-05	0.000468	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—RHOA—urinary bladder cancer	1.24e-05	0.000424	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.19e-05	0.000408	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.18e-05	0.000405	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.14e-05	0.000392	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—ERBB2—urinary bladder cancer	1.14e-05	0.000392	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.03e-05	0.000353	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—EP300—urinary bladder cancer	9.82e-06	0.000336	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—CDKN1A—urinary bladder cancer	9.78e-06	0.000335	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—PTEN—urinary bladder cancer	9.76e-06	0.000334	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—EP300—urinary bladder cancer	9.31e-06	0.000319	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—SRC—urinary bladder cancer	9.05e-06	0.00031	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PTEN—urinary bladder cancer	8.18e-06	0.00028	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—MYC—urinary bladder cancer	8.11e-06	0.000278	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—EGFR—urinary bladder cancer	7.94e-06	0.000272	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—EP300—urinary bladder cancer	7.8e-06	0.000267	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—KRAS—urinary bladder cancer	7.5e-06	0.000257	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—HRAS—urinary bladder cancer	6.37e-06	0.000218	CbGpPWpGaD
